Evidence map›Paper›PMID 29434227›Full record

ArticleScientific reports2018

The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.

Shyam S Chaurasia, Rayne R Lim, Bhav H Parikh, Yeo Sia Wey, Bo Bo Tun, Tien Yin Wong, Chi D Luu, Rupesh Agrawal, Arkasubhra Ghosh, Alessandra Mortellaro and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.Signal transduction and targeted therapy · 2024 · on this map
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Shyam S ChaurasiaOcular Immunology and Angiogenesis Lab, Department of Veterinary Medicine & Surgery, University of Missouri, Columbia, MO, USA. chaurasias@missouri.edu.
Rayne R LimOcular Immunology and Angiogenesis Lab, Department of Veterinary Medicine & Surgery, University of Missouri, Columbia, MO, USA.
Bhav H ParikhTranslational Pre-Clinical Model Platform, Singapore Eye Research Institute, Singapore, Singapore.
Yeo Sia WeyTranslational Pre-Clinical Model Platform, Singapore Eye Research Institute, Singapore, Singapore.
Bo Bo TunTranslational Pre-Clinical Model Platform, Singapore Eye Research Institute, Singapore, Singapore.ORCID 0000-0002-2013-8379
Tien Yin WongTranslational Pre-Clinical Model Platform, Singapore Eye Research Institute, Singapore, Singapore.
Chi D LuuCentre for Eye Research Australia, Department of Surgery (Ophthalmology), University of Melbourne, Melbourne, Australia.
Rupesh AgrawalNational Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.ORCID 0000-0002-6662-5850
Arkasubhra GhoshGROW laboratory, Narayana Nethralaya, Bangalore, India.ORCID 0000-0002-6570-5891
Alessandra MortellaroSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID 0000-0003-1744-2430
Elizabeth RackoczyCentre for Ophthalmology and Visual Sciences, University of Western Australia, Perth, WA, 6009, Australia.
Rajiv R MohanOcular Immunology and Angiogenesis Lab, Department of Veterinary Medicine & Surgery, University of Missouri, Columbia, MO, USA.
Veluchamy A BarathiTranslational Pre-Clinical Model Platform, Singapore Eye Research Institute, Singapore, Singapore.
Singapore Eye Research Institute · SGHarry S. Truman Memorial Veterans' Hospital · USAgency for Science, Technology and Research · SGNarayana Nethralaya · INTan Tock Seng Hospital · SGThe University of Melbourne · AUThe University of Western Australia · AU

Funding

Gene Therapy in the CorneaR01EY017294 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2007 to 2018
$4.3M
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal DiseasesI01BX000357 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Rajiv Ravindra Mohan · 2009 to 2026
–
BLRD VA I01 BX000357NEI NIH HHS R01 EY017294
6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a retinal microvascular disease characterized by inflammatory and angiogenic pathways. In this study, we evaluated NLRP3 inflammasome in a double transgenic mouse model, Akimba (Ins2

Indexed as

AnimalsCytokinesDiabetic RetinopathyDisease Models, AnimalElectroretinographyFluorescein AngiographyGlial Fibrillary Acidic ProteinHumansInsulinMiceMice, TransgenicNeovascularization, PathologicNLR Family, Pyrin Domain-Containing 3 ProteinRetinaTomography, Optical CoherenceVascular Endothelial Growth Factor ACytokinesGlial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseIns2 protein, mouseInsulinNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID29434227
PMCPMC5809448
OpenAlexW2805386022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.